Legal & General Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $88.5M | Sell |
|
|||||
|
2022
Q2 | $93.1M | Sell |
|
|||||
|
2022
Q1 | $129M | Buy |
|
|||||
|
2021
Q4 | $131M | Sell |
|
|||||
|
2021
Q3 | $119M | Buy |
|
|||||
|
2021
Q2 | $112M | Buy |
|
|||||
|
2021
Q1 | $92.6M | Buy |
|
|||||
|
2020
Q4 | $92.5M | Buy |
|
|||||
|
2020
Q3 | $77.9M | Sell |
|
|||||
|
2020
Q2 | $68.3M | Sell |
|
|||||
|
2020
Q1 | $41.8M | Buy |
|
|||||
|
2019
Q4 | $46.3M | Buy |
|
|||||
|
2019
Q3 | $45.3M | Buy |
|
|||||
|
2019
Q2 | $66.1M | Buy |
|
|||||
|
2019
Q1 | $71.8M | Buy |
|
|||||
|
2018
Q4 | $63.4M | Buy |
|
|||||
|
2018
Q3 | $75.2M | Buy |
|
|||||
|
2018
Q2 | $25.6M | Buy |
|
|||||
|
2018
Q1 | $17.6M | Buy |
|
|||||
|
2017
Q4 | $7.6M | Buy |
|
|||||
|
2017
Q3 | $6.12M | Buy |
|
|||||
|
2017
Q2 | $4.57M | Buy |
|
|||||
|
2017
Q1 | $3.18M | Buy |
|
|||||
|
2016
Q4 | $1.28M | Buy |
|
|||||
|
2016
Q3 | $645K | Buy |
|
|||||
|
2016
Q2 | $545K | Sell |
|
|||||
|
2016
Q1 | $935K | Buy |
|
|||||
|
2015
Q4 | $728K | Buy |
|
|||||
|
2015
Q3 | $690K | Buy |
|
|||||
|
2015
Q2 | $480K | Buy |
|
|||||
|
2015
Q1 | $514K | Buy |
|
|||||
|
2014
Q4 | $227K | Hold |
|
|||||
|
2014
Q3 | $147K | Buy |
|